Gastric Cancer Diagnostic Procedure Market Demand Supply Growth Factors Latest Rising Trend and Forecast to 2028

The "Gastric Cancer Diagnostic Procedure Market" is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

The presence of a huge patient population with gastrointestinal tumors, lymphoma, and adenocarcinoma, the increase in the geriatric population, and the rise in alcohol consumption and smoking are among the factors contributing to the growing gastric cancer diagnostic procedure market size. However, the shortage of medical laboratory professionals hinders the growth of the gastric cancer diagnostic procedures market. Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.

Get a Sample PDF of report @: https://www.premiummarketinsights.com/sample/TIP00073713?utm_source=OpenPr&utm_medium=10688

Companies Profiled in this report includes:

• Atlas-Link Biotech Co Ltd
• Bio-Rad Laboratories Inc
• MiRXES Pte Ltd
• Agilent Technologies Inc
• F. Hoffmann-La Roche Ltd
• bioMerieux SA
• Thermo Fisher Scientific Inc
• Illumina Inc
• Vela Diagnostics Holding Pte Ltd
• Myraid Genetics Inc.

Many market players and research institutes operating in the gastric cancer diagnostics market are developing advanced products to expand their product portfolios and increase their market shares. They invest significant amounts in R&D to develop advanced products. A few of the recent developments related to gastric cancer diagnostic platforms are mentioned below:

Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, developed the world's first artificial intelligence (AI) platform to detect cancer. Its AI algorithms analyze images of biopsies and can pinpoint their location and grade the tumor. These results help pathologists diagnose gastric cancer accurately. In June 2021, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to Ibex's Galen platform, which will expedite the clinical review and regulatory approval of its platform. Galen Gastric is an integrated diagnostics and quality control solution that supports pathologists in the detection of gastric cancer, dysplasia, H. pylori, and other important clinical findings.

Get Full Report here @: https://www.premiummarketinsights.com/reports-tip/gastric-cancer-diagnostic-procedure-market

Gastric Cancer Diagnostic Procedure Market Segmentation:

By Healthcare Providers:
• Diagnostic Laboratories
• Hospitals
• Cancer Research Institutes
• Oncology Specialty Clinics

By Symptom Types:
• Symptomatic
• Asymptomatic

By Body Fluid:
• Blood
• Urine
• Saliva
• Stomach Wash/Gastric Juice
• Tissue

By Procedure:
• Endoscopic Procedure
• Biopsy and Tissue Tests
• Lab Tests
• In-Vitro Diagnostic Tests
• Imaging Tests
• Molecular Diagnostics
• Multiplexing Molecular Diagnostics and Immunoassay

By Offerings:
• Instruments
• Reagents and Consumables
• Services

By Disease Indication:
• Early Gastric Cancer
• Gastric Cancer Advanced Types

Healthcare Providers-Based Insights

Based on healthcare providers, the global gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, others. In 2022, the hospitals segment held the largest share of the market. The cancer research institutes segment is expected to grow at the fastest rate during the coming years.

Buy this report @: https://www.premiummarketinsights.com/buy/TIP00073713?utm_source=OpenPr&utm_medium=10688

Contact Us:

If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.